Investing Profile

Paul Walker

VCInvestor
General Partner at New Enterprise Associates (NEA)
nea.com/team/paul-walkerMenlo Park, California
Photo of Paul Walker, General Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$2.0M - $50.0M
$25.0M
20
$6.2B
CompanyStageDateRound SizeTotal Raised
Allakos
Post Ipo EquitySep 2022$150M
Series BDec 2017$100M
$290M
Co-investors: John McKearn (RiverVest), Farah Champsi (InterWest)
Regulus Therapeutics
Post Ipo EquityNov 2021$35M
Post Ipo EquityJan 2017
$35M
erytech
Post Ipo EquityJan 2020
$16M
Co-investors: Catherine Boule (Karista)
Geron
Post Ipo EquityJan 2020
$130M
Co-investors: Himani Bhalla (Hercules Capital)
Xenon Pharmaceuticals
Post Ipo EquityJan 2019
Co-investors: Blake Wu (New Enterprise Associates (NEA))
CTI BioPharma
Post Ipo EquityFeb 2018$69M
$69M
Addex Therapeutics
Post Ipo EquityFeb 2017$3M
$85M
Co-investors: Antoine Papiernik Papiernik (Soffinova Partners)
Immunomedics
Post Ipo EquityJan 2017